BioCardia, Inc. (BCDA) vs Dyadic International, Inc. (DYAI)
A side-by-side comparison of BioCardia, Inc. and Dyadic International, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BCDA
BioCardia, Inc.
$1.08HealthcareDelayed quote: Oct 6, 2026, 12:21 PM EDT
DYAI
Dyadic International, Inc.
$0.45HealthcareDelayed quote: Oct 6, 2026, 12:20 PM EDT
Total return — BCDA vs DYAI
growth of $100 · dividends reinvested · last 10yBCDA -99.8% (-46.5%/yr)DYAI -70.5% (-11.5%/yr)DYAI compounded faster over this window
Log scale — wide-divergence pair
BCDA DYAI
BCDA vs DYAI: by the numbers
- •DYAI is the larger company ($16M vs $16M market cap).
- •Both run net losses; BCDA's is the smaller (0.00% vs -219.50% net margin).
Metrics side by side
Valuation
| Metric | BCDA | DYAI |
|---|---|---|
| P/S ratio | N/A | 4.75 |
| P/B ratio | 5.95 | N/A |
Profitability
| Metric | BCDA | DYAI |
|---|---|---|
| Gross margin | 0.00% | -88.25% |
| Operating margin | 0.00% | -579.88% |
| Net margin | 0.00% | -219.50% |
| ROE | -271.81% | N/A |
| ROIC | -273.70% | -279.48% |
Growth (annualized)
| Metric | BCDA | DYAI |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -5.11% |
| Total return CAGR (5Y) | -61.39% | -38.53% |
Frequently asked
- How have BCDA and DYAI total returns compared?
- Over the past 10 years, BCDA delivered -46.74% and DYAI delivered -11.56% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.